Adoptive JC Virus-Specific T Lymphocytes for the Treatment of Progressive Multifocal Leukoencephalopathy: Experience from Two Italian Centers
Viruses · 2025
DOI: 10.3390/v17070934 ↗Kurz gefasst
Multizentrische Studie in der Zeitschrift Viruses, 2025. Verfasst von Maria Magdalena Pocora und 15 weiteren Autor:innen. Beteiligte Einrichtung: Department of Brain and Behavioural Sciences, University of Pavia, 27100 Pavia, Italy. Hauptthemen laut MEDLINE: Leukoencephalopathy, Progressive Multifocal, JC Virus, T-Lymphocytes, Immunotherapy, Adoptive. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 24 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Ministero della Salute, Ministero della Salute, Ricerca Corrente.
Abstract (Originalsprache)
Background
Progressive multifocal leukoencephalopathy (PML) is a rare but fatal disease caused by John Cunningham virus (JCV) in immunocompromised individuals, with no effective antiviral treatment currently available. This study aimed to evaluate the feasibility of adoptive JCV-specific T lymphocyte therapy in patients with PML.
Methods
Nineteen patients meeting the 2013 consensus criteria for “definite PML” were included, and JCV-specific T lymphocytes expanded from autologous or allogeneic peripheral blood mononuclear cells (PBMCs) using JCV antigen-derived peptides were administered. Clinical outcomes were monitored through neuroimaging and biological markers.
Results
The mean age at diagnosis was 56.5 years, with a mean time to treatment of three months. Patients received a median of two infusions. At 12 months, six patients (31.6%) survived, while 13 (68.4%) had died, primarily due to PML progression. Survivors had a higher median baseline Karnofsky performance scale (KPS) score (50% vs. 30%, p = 0.41) and a significantly shorter diagnosis delay. MRI assessment showed a reduced disease burden in survivors, and JCV-DNA copy numbers decreased overall. One case of immune reconstitution inflammatory syndrome (IRIS) was observed.
Conclusions
Adoptive JCV-specific T lymphocytes may represent a safe therapeutic option for PML patients, and the MRI burden and JCV-DNA copy may serve as biomarkers for disease monitoring.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Brain and Behavioural Sciences, University of Pavia, 27100 Pavia, Italy.
- IRCCS Mondino Foundation, 27100 Pavia, Italy.
- Neuroncology Unit, IRCCS Mondino Foundation, 27100 Pavia, Italy.
- Neurology Unit, IRCCS Ospedale San Raffaele, 20132 Milan, Italy.
- Unit of Infectious Diseases, IRCCS San Raffaele Scientific Institute, 20132 Milan, Italy.
- School of Medicine, San Raffaele Vita-Salute University, 20132 Milan, Italy.
ORCID-Profile: Maria Magdalena Pocora, Paola Bini, Giulia Berzero, Paola Cinque, Gaia Catalano, Matteo Paoletti, Anna Pichiecchio, Fulvio Tartara, Enrico Marchioni
Förderung
- Ministero della Salute
- Ministero della Salute, Ricerca Corrente
Zitieren
APA
Pocora, M. M., Bini, P., Berzero, G., Vegezzi, E., Diamanti, L., Gastaldi, M., Cinque, P., Catalano, G., Paoletti, M., Pichiecchio, A., Tartara, F., Basso, S., Baldanti, F., Furione, M., Comoli, P., & Marchioni, E. (2025). Adoptive JC Virus-Specific T Lymphocytes for the Treatment of Progressive Multifocal Leukoencephalopathy: Experience from Two Italian Centers. Viruses. https://doi.org/10.3390/v17070934
Vancouver
Pocora MM, Bini P, Berzero G, Vegezzi E, Diamanti L, Gastaldi M, et al. Adoptive JC Virus-Specific T Lymphocytes for the Treatment of Progressive Multifocal Leukoencephalopathy: Experience from Two Italian Centers. Viruses. 2025. doi:10.3390/v17070934
BibTeX
@article{Pocora2025,
author = {Pocora, Maria Magdalena and Bini, Paola and Berzero, Giulia and Vegezzi, Elisa and Diamanti, Luca and Gastaldi, Matteo and Cinque, Paola and Catalano, Gaia and Paoletti, Matteo and Pichiecchio, Anna and Tartara, Fulvio and Basso, Sabrina and Baldanti, Fausto and Furione, Milena and Comoli, Patrizia and Marchioni, Enrico},
title = {Adoptive JC Virus-Specific T Lymphocytes for the Treatment of Progressive Multifocal Leukoencephalopathy: Experience from Two Italian Centers},
journal = {Viruses},
year = {2025},
doi = {10.3390/v17070934}
}
EUVIMED